A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas
Clinical trial NCT02750891 · COMPLETED
Trial details
- NCT number
- NCT02750891
- Sponsor
- Sumitomo Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2020-01-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.